Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:MNK

Mallinckrodt (MNK) Stock Price, News & Analysis

Mallinckrodt logo

About Mallinckrodt Stock (NYSE:MNK)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.14
$0.75
52-Week Range
N/A
Volume
39,227 shs
Average Volume
2.62 million shs
Market Capitalization
$1.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MNK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mallinckrodt and its competitors with MarketBeat's FREE daily newsletter.

MNK Stock News Headlines

Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
See More Headlines

MNK Stock Analysis - Frequently Asked Questions

Mallinckrodt plc (NYSE:MNK) announced its quarterly earnings data on Tuesday, August, 4th. The company reported $1.89 earnings per share for the quarter, beating the consensus estimate of $1.34 by $0.55. The company's quarterly revenue was down 14.9% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mallinckrodt investors own include Bristol Myers Squibb (BMY), Gilead Sciences (GILD), Micron Technology (MU), Endo International (ENDP), Bausch Health Cos (BHC), Meta Platforms (META) and Gerdau (GGB).

Company Calendar

Last Earnings
8/04/2020
Today
7/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:MNK
CIK
1567892
Fax
N/A
Employees
2,700
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($116.19)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
-82.59%
Pretax Margin
N/A
Return on Equity
20.32%
Return on Assets
2.49%

Debt

Debt-to-Equity Ratio
1.18
Current Ratio
0.57
Quick Ratio
0.31

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$47.48 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
13,170,000
Free Float
13,131,000
Market Cap
$1.58 million
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NYSE:MNK) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners